跳至主要内容
临床试验/IRCT20131009014957N7
IRCT20131009014957N7尚未招募3 期

The effect of sodium pentaborate (NaB) supplementation on bone density, serum levels of bone turnover markers and inflammation-related microRNAs in postmenopausal women with primary osteoporosis: a triple blind randomized controlled trial.

Tabriz University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 65 years(—)
性别
Female

入选标准

  • Postmenopausal women aged 50 to 65 years
  • Menstrual cessation for at least 12 consecutive months
  • Bone density between -1 to -2.5 in the lumbar or femoral neck

排除标准

  • Renal diseases and renal failure
  • Bone disease other than osteopenia
  • The use of medications that affect bone metabolism

研究者

相似试验

The effect of sodium pentaborate (NaB)... | 临床试验